Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.77
-0.13 (-1.88%)
At close: May 15, 2026, 4:00 PM EDT
6.82
+0.05 (0.74%)
After-hours: May 15, 2026, 7:56 PM EDT
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $1.3 billion as of May 15, 2026. Its market cap has increased by 6.88% in one year.
Market Cap
1.30B
Enterprise Value
773.69M
1-Year Change
6.88%
Ranking
Category
Stock Price
$6.77
Market Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $1.30B, an increase of 288.90%. That is a compound annual growth rate of 13.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.30B | -58.13% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.33B |
| GH Research | 1.33B |
| Biohaven | 1.32B |
| SELLAS Life Sciences Group | 1.32B |
| MapLight Therapeutics | 1.30B |
| ArriVent BioPharma | 1.30B |
| Fortrea Holdings | 1.29B |
| MoonLake Immunotherapeutics | 1.28B |